Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C Mange

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Advances in Therapy|December 16, 2024
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung DiseaseKelly P McCarrier, Mariam Hassan, Dayton W Yuen, et al.
ERJ Open Research|July 13, 2022
Amikacin liposome inhalation suspension clinical benefit-risk assessment for refractory <i>Mycobacterium avium</i> complex lung diseaseTheodore K Marras, Mariam Hassan, Kevin C Mange, et al.
Clinical Pharmacokinetics|August 17, 2022
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis BronchiectasisJames D Chalmers, Helen Usansky, Christopher M Rubino, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Allograft survival following adult-to-adult living donor liver transplantationPeter L Abt, Kevin C Mange, Kim M Olthoff, et al.
Transplantation|June 30, 2004
Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipientsErgun Velidedeoglu, Kevin C Mange, Adam Frank, et al.
Journal of Patient-Reported Outcomes|October 16, 2025
Psychometric validation of the PROMIS Fatigue-Short Form 7a in adults with newly diagnosed or recurrent Mycobacterium avium complex (MAC) lung disease: the ARISE and ENCORE studiesKevin C Mange, Daniel Serrano, Mariam Hassan, et al.
BMC Infectious Diseases|March 13, 2022
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversionChristina M Mingora, Bryan A Garcia, Kevin C Mange, et al.
Kidney International|August 26, 2004
Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed functionKevin C Mange, Eline Luning Prak, Malek Kamoun, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung DiseaseChristopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 19, 2021
Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung DiseaseChristopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Advances in Therapy|December 16, 2024
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung DiseaseKelly P McCarrier, Mariam Hassan, Dayton W Yuen, et al.
ERJ Open Research|July 13, 2022
Amikacin liposome inhalation suspension clinical benefit-risk assessment for refractory <i>Mycobacterium avium</i> complex lung diseaseTheodore K Marras, Mariam Hassan, Kevin C Mange, et al.
Clinical Pharmacokinetics|August 17, 2022
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis BronchiectasisJames D Chalmers, Helen Usansky, Christopher M Rubino, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Allograft survival following adult-to-adult living donor liver transplantationPeter L Abt, Kevin C Mange, Kim M Olthoff, et al.
Transplantation|June 30, 2004
Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipientsErgun Velidedeoglu, Kevin C Mange, Adam Frank, et al.
Journal of Patient-Reported Outcomes|October 16, 2025
Psychometric validation of the PROMIS Fatigue-Short Form 7a in adults with newly diagnosed or recurrent Mycobacterium avium complex (MAC) lung disease: the ARISE and ENCORE studiesKevin C Mange, Daniel Serrano, Mariam Hassan, et al.
BMC Infectious Diseases|March 13, 2022
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversionChristina M Mingora, Bryan A Garcia, Kevin C Mange, et al.
Kidney International|August 26, 2004
Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed functionKevin C Mange, Eline Luning Prak, Malek Kamoun, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung DiseaseChristopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 19, 2021
Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung DiseaseChristopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, et al.
Pageof 3